Intervention Group:Qinghua Decoction+basic treatment

2 trials

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Conditions

Nonalcoholic fatty liver disease

Early Phase 1

Clinical Study on Qinghua Decoction to Reduce the Risk of Coronary Artery Disease in Patients with NAFLD with Turbid Phlegm and Internal Resistance

Active, not recruitingITMCTR2000003628

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese MedicineNonalcoholic fatty liver disease

Start: 2020-10-01Updated: 2023-02-20

Clinical Study on Qinghua Decoction to Reduce the Risk of Coronary Artery Disease in Patients with NAFLD with Turbid Phlegm and Internal Resistance

Active, not recruitingChiCTR2000036225

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese MedicineNonalcoholic fatty liver disease

Start: 2020-10-01Updated: 2020-09-07